These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 24469757)
1. Acute dysphagia after myocardial infarction: an unusual complication of anticoagulation therapy. Wiedemann S; Henke C; Strasser RH Kardiol Pol; 2014; 72(1):87. PubMed ID: 24469757 [No Abstract] [Full Text] [Related]
2. Anticoagulation plus aspirin following acute myocardial infarction: yes or no ... and if the latter, why not? Lip GY; Varma C Thromb Res; 2006; 118(4):429-32. PubMed ID: 16274734 [No Abstract] [Full Text] [Related]
3. Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes. Lopes RD; Li L; Granger CB; Wang TY; Foody JM; Funk M; Peterson ED; Alexander KP Am J Med; 2012 Sep; 125(9):897-905. PubMed ID: 22795814 [TBL] [Abstract][Full Text] [Related]
4. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel. Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic therapy for non ST-segment elevation acute coronary syndromes: focus on antithrombotic therapy. Danchin N; Aïssaoui N Cardiovasc Drugs Ther; 2010 Aug; 24(4):325-30. PubMed ID: 20714797 [TBL] [Abstract][Full Text] [Related]
6. Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel--Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38). Hochholzer W; Wiviott SD; Antman EM; Contant CF; Guo J; Giugliano RP; Dalby AJ; Montalescot G; Braunwald E Circulation; 2011 Jun; 123(23):2681-9. PubMed ID: 21606391 [TBL] [Abstract][Full Text] [Related]
11. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38). Kohli P; Udell JA; Murphy SA; Cannon CP; Antman EM; Braunwald E; Wiviott SD J Am Coll Cardiol; 2014 Jan; 63(3):225-32. PubMed ID: 24140678 [TBL] [Abstract][Full Text] [Related]
12. Triple antithrombotic therapy with prasugrel in the stented patient: concern for more bleeding. Gurbel PA; Tantry US J Am Coll Cardiol; 2013 May; 61(20):2067-9. PubMed ID: 23524214 [No Abstract] [Full Text] [Related]
13. Response to antiplatelet treatment: from genes to outcome. Giusti B; Abbate R Lancet; 2010 Oct; 376(9749):1278-81. PubMed ID: 20801497 [No Abstract] [Full Text] [Related]
14. Occult bleeding in three different antithrombotic regimes after myocardial infarction. A WARIS-II subgroup analysis. Hurlen M; Eikvar L; Seljeflot I; Arnesen H Thromb Res; 2006; 118(4):433-8. PubMed ID: 16139331 [TBL] [Abstract][Full Text] [Related]
15. ["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit]. Wallén H; Agren A; Nekludov M Lakartidningen; 2007 Nov 28-Dec 4; 104(48):3640-2. PubMed ID: 18193674 [No Abstract] [Full Text] [Related]
16. Fatal bleedings with prasugrel as part of triple antithrombotic therapy. Savonitto S; Ferri M; Corrada E Rev Esp Cardiol (Engl Ed); 2014 Mar; 67(3):225-6. PubMed ID: 24774401 [No Abstract] [Full Text] [Related]
17. Safety and efficacy of antiplatelet and antithrombotic therapy in acute coronary syndrome patients with chronic kidney disease. Basra SS; Tsai P; Lakkis NM J Am Coll Cardiol; 2011 Nov; 58(22):2263-9. PubMed ID: 22093501 [TBL] [Abstract][Full Text] [Related]
18. Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation. Sarafoff N; Martischnig A; Wealer J; Mayer K; Mehilli J; Sibbing D; Kastrati A J Am Coll Cardiol; 2013 May; 61(20):2060-6. PubMed ID: 23524219 [TBL] [Abstract][Full Text] [Related]